(2377–2436) Systemic Lupus Erythematosus – Diagnosis, Manifestations, & Outcomes Poster III

Tuesday, October 28, 2025

10:30 AM - 12:30 PM Central Time

Location: Hall F1

CE: 0.00

Presentations:

10:30 AM - 12:30 PM Central Time

A Comparison of Patients with Older Onset vs. Younger Onset SLE: A Retrospective Cohort Study
Abstract Poster Presenter: Chelsea Guan, MD – University Hospitals Cleveland Medical Center/Case Western Reserve University
10:30 AM - 12:30 PM Central Time

A Machine Learning Algorithm Based on a 15-autoantibody Profile by a Novel Fully Automated Multiplexed Microarray Immunoassay for the Diagnosis of Autoimmune Connective Tissue Diseases
Abstract Poster Presenter: Gerber Gomez, MD, MSc (he/him/his) – AliveDx Suisse SA
10:30 AM - 12:30 PM Central Time

Analysis of Histopathological Changes in the Placenta of Patients with Systemic Lupus Erythematosus
Abstract Poster Presenter: Evandro Klumb, n/a (he/him/his) – UERJ - Universidade do Estado do Rio de Janeiro
10:30 AM - 12:30 PM Central Time

Analytical Performance of a Fully Automated Multiplexed Microarray Immunoassay for the Simultaneous Detection of Fifteen Autoantibodies Associated with Connective Tissue Diseases in a Reference Laboratory in Southern France
Abstract Poster Presenter: Gerber Gomez, MD, MSc (he/him/his) – AliveDx Suisse SA
10:30 AM - 12:30 PM Central Time

Analytical Performance of the hep-2 Substrate Diagnostic Kit for ANA as an Initial Step in the Evaluation of a Novel Fully Automated IFA Analyzer in a Laboratory in England
Abstract Poster Presenter: Gerber Gomez, MD, MSc (he/him/his) – AliveDx Suisse SA
10:30 AM - 12:30 PM Central Time

Anti-dense Fine Speckled 70 Antibodies in Undefined Disease, Systemic Autoimmune Rheumatic Diseases and Controls
Abstract Poster Presenter: Meghna Gavali, MBBS, MD (she/her/hers) – Nizam's institute of medical sciences ,Hyderabad
10:30 AM - 12:30 PM Central Time

Antinuclear Antibody Positivity in Patients with Psoriasis and Psoriatic Arthritis and the Risk of Developing Clinical Symptoms of SLE Following TNF Inhibitor Therapy
Abstract Poster Presenter: Damira Sereda, MD – Stamford
10:30 AM - 12:30 PM Central Time

anti-trim72 Auto-antibodies in Systemic Lupus Erythematosus Patients and a Lupus Mouse Model with Myocarditis Compromise Membrane Repair in Mouse & Human Cardiomyocytes
Abstract Poster Presenter: Braden Zeno, BS – Ohio State University
10:30 AM - 12:30 PM Central Time

Associations Between Serum Levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) and Activity and Chronicity Features in Diagnostic and Per-protocol Repeat Kidney Biopsies in Patients with Lupus Nephritis
Abstract Poster Presenter: Ioannis Parodis, MD, PhD – Karolinska Institutet and Karolinska University Hospital, Department of Medicine Solna, Division of Rheumatology
10:30 AM - 12:30 PM Central Time

Autoantibody Clusters and SIGLEC1 are Predictive of Systemic Lupus Erythematosus Development
Abstract Poster Presenter: May Choi, MD, FRCPC, MPH – University of Calgary
10:30 AM - 12:30 PM Central Time

Autoimmune Hemolytic Anemia in SLE: A Real-World National Cohort Study
Abstract Poster Presenter: Ansaam Daoud, MD – Case Western Reserve University/University Hospitals
10:30 AM - 12:30 PM Central Time

Bone marrow- activity on 18F-FDG PET/CT as a Predictor of Hematologic Manifestations in Systemic Lupus Erythematosus
Abstract Poster Presenter: Sungwon Ko, MD – ASAN MEDICAL CENTER
10:30 AM - 12:30 PM Central Time

Clinical and Sociodemographic Factors Associated with Diagnostic Delays in Pediatric Lupus Patients
Abstract Poster Presenter: Rebecca Hetrick, MD, MS – Indiana University School of Medicine
10:30 AM - 12:30 PM Central Time

Clinical features of Elderly-onset Systemic Lupus Erythematosus
Abstract Poster Presenter: Jessica Dai, BS – New York University Grossman School of Medicine
10:30 AM - 12:30 PM Central Time

Cluster Analysis of Autoantibodies in Patients with Systemic Lupus Erythematosus
Abstract Poster Presenter: Oihane Ibarguengoitia-Barrena, MD – Galdakao-Usansolo University Hospital
10:30 AM - 12:30 PM Central Time

Correlation between Activity Index, Organ Damage Index, and HAQ in Systemic Lupus Erythematosus: a single-center study
Abstract Poster Presenter: Carmen Lasa Teja, n/a – Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain.
10:30 AM - 12:30 PM Central Time

Cutaneous Lupus Activity Investigator’s Global Assessment―Revised (CLA-IGA-R) Content Validity: Cutaneous Lupus Erythematosus (CLE) Patient Qualitative Study
Abstract Poster Presenter: Joseph Merola, MD, MSc, FACR, FAAD – UT Southwestern Medical Center
10:30 AM - 12:30 PM Central Time

Differences in Dyspigmentation and Scarring Across Cutaneous Lupus Erythematosus Categories and Subtypes
Abstract Poster Presenter: Shae Chambers, BA – University of Pennsylvania
10:30 AM - 12:30 PM Central Time

Differential Risk of Inpatient Admissions Among SLE Subgroups: A Population-Based Analysis
Abstract Poster Presenter: Jaime Flores Gouyonnet, MD – Mayo Clinic
10:30 AM - 12:30 PM Central Time

Direct and Indirect Costs Associated with Damage Accrual: Results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
Abstract Poster Presenter: Megan Barber, MD, PhD – University of Calgary
10:30 AM - 12:30 PM Central Time

Direct Medical Cost Burden of Cutaneous Lupus Erythematosus (CLE): A Comparison with Psoriasis, Atopic Dermatitis, and a General Population
Abstract Poster Presenter: Joseph Merola, MD, MSc, FACR, FAAD – UT Southwestern Medical Center
10:30 AM - 12:30 PM Central Time

Disease Activity Independently Correlates with Cognitive Impairment in Systemic Lupus Erythematosus
Abstract Poster Presenter: Steven Bieser, MD – Northwestern University Feinberg School of Medicine, NMH hospital
10:30 AM - 12:30 PM Central Time

Does Obesity Influence Disease Activity and Biomarkers in Systemic Lupus Erythematosus Patients?: A Retrospective Study
Abstract Poster Presenter: Daniyal Nadeem, MD – Louisiana state university health shreveport
10:30 AM - 12:30 PM Central Time

Dried Blood Spots for Remote ANA and Autoantibody Screening
Abstract Poster Presenter: Feng Yun Li, MD – University of Calgary
10:30 AM - 12:30 PM Central Time

Duffy Null Genotype and Autoantibodies Synergistically Contribute to Severe Leukopenia in Systemic Lupus Erythematosus
Abstract Poster Presenter: Valerie Lewis, Ph.D. (she/her/hers) – Oklahoma Medical Research Foundation
10:30 AM - 12:30 PM Central Time

Evaluating the Readability and Comprehension of Patient Education Materials for Systemic Lupus Erythematosus (SLE) Available Online
Abstract Poster Presenter: Meenakshi Jolly, MD – Rush University
10:30 AM - 12:30 PM Central Time

Evolving Trends in Pulmonary Arterial Hypertension among Systemic Lupus Erythematosus Patients: A Nationwide Analysis
Abstract Poster Presenter: Maria Emilia Romero Noboa, MD – University of Alabama at Birmingham
10:30 AM - 12:30 PM Central Time

Factors Associated With Fatigue In Systemic Lupus Erythematosus: Data From The Almenara Lupus Cohort
Abstract Poster Presenter: Alvaro Oyarce-Calderón, Sr, MD (he/him/his) – Hospital Nacional Guillermo Almenara Irigoyen
10:30 AM - 12:30 PM Central Time

Factors Influencing Time to Diagnosis in Systemic Lupus Erythematosus: A Real-World Retrospective Analysis
Abstract Poster Presenter: April Barnado, MD, MSc – Vanderbilt University Medical Center
10:30 AM - 12:30 PM Central Time

High-Resolution Proteomic Profiling Validates BAFF Pathway Modulation and Reveals Novel Biomarker Signatures in Belimumab Treatment
Abstract Poster Presenter: Ioannis Parodis, MD, PhD – Karolinska Institutet and Karolinska University Hospital, Department of Medicine Solna, Division of Rheumatology
10:30 AM - 12:30 PM Central Time

Hydroxychloroquine and Adverse Cardiovascular Outcomes in Pregnant Patients with Systemic Lupus Erythematosus
Abstract Poster Presenter: Mariana Gonzalez-Trevino, MD – Vanderbilt University Medical Center
10:30 AM - 12:30 PM Central Time

Identification of an LN endotype linked to intestinal expansion of Pathogenic Strains of a Pathobiont Bacterium that induces Systemic Thrombo-inflammatory Pathways directly measurable in Urine
Abstract Poster Presenter: Gregg Silverman, MD – NYU Grossman School of Medicine
10:30 AM - 12:30 PM Central Time

Immune Cell/Pathway-Specific Polygenic Risk Scores Reveal Immune Pathway Associations in Childhood-Onset Lupus Nephritis
Abstract Poster Presenter: Liyoung Kim, MD (she/her/hers) – Boston Children's Hospital
10:30 AM - 12:30 PM Central Time

Impact of Immunosuppressive Regimens on Major Cardiac Events in Patients with Systemic Lupus Erythematosus (SLE): A Survival Analysis
Abstract Poster Presenter: Emily Cosentino, MD – Icahn School of Medicine at Mount Sinai
10:30 AM - 12:30 PM Central Time

Improving Clinical Outcomes In SLE Arthritis Trials: Post-Hoc Analysis Of A Prospective Intervention Study
Abstract Poster Presenter: Ed Vital, MD – University of Leeds
10:30 AM - 12:30 PM Central Time

In-patient Outcomes of Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Syndrome in SLE: US National Inpatient Database (2021-2022)
Abstract Poster Presenter: Nattanicha Chaisrimaneepan, MD – Texas Tech University Health Sciences Center
10:30 AM - 12:30 PM Central Time

Kidney-Specific Four-Protein Index Outperforms Conventional Measures for Detecting Early Kidney Damage in Lupus Nephritis and Diabetic Kidney Disease
Abstract Poster Presenter: Sepehr Taghavi, MSc – Exagen Inc
10:30 AM - 12:30 PM Central Time

Lupus Damage Index Revision – Item Generation and Reduction Phases
Abstract Poster Presenter: Burak Kundakci, PhD, MSc – University of Manchester
10:30 AM - 12:30 PM Central Time

Machine Learning in SLE Diagnosis: Performance of the SLE Risk Probability Index Questionnaire in a Multicenter Cohort of Patients with Systemic Lupus Erythematosus
Abstract Poster Presenter: Joan Manuel Dapeña, Sr, MD (he/him/his) – Sanatorio Dr. Julio Mendez
10:30 AM - 12:30 PM Central Time

Machine Learning-Based Artificial Intelligence in Systemic Lupus Erythematosus: A Systematic Review of Outcome Prediction and Patient Stratification
Abstract Poster Presenter: Jorge Juan Fragio Gil, MD;PhD (he/him/his) – Hospital General Universitario
10:30 AM - 12:30 PM Central Time

Mapping Neurological Involvement, Regional Disparities, and Moderators of the Central Nervous System in Adult-Onset Systemic Lupus Erythematosus: A Global Systematic Review and Meta-Analysis
Abstract Poster Presenter: Jorge Juan Fragio Gil, MD;PhD (he/him/his) – Hospital General Universitario
10:30 AM - 12:30 PM Central Time

mHealth-enabled Peer Coaching for Fatigue in Systemic Lupus Erythematosus (SLE): Preliminary Results from the Restore Energy, Activity Can Help (REACH) Pilot Randomized Controlled Trial
Abstract Poster Presenter: Shanthini Kasturi, MD;MS (she/her/hers) – Tufts Medical Center
10:30 AM - 12:30 PM Central Time

Neutrophil Transcriptomics in SLE: Exploring Intrinsic, Ex Vivo Adaptation, and CAR-T Cell Therapy-Induced Changes
Abstract Poster Presenter: Roberto Caricchio, MD – University of Massachusetts Chan Medical School
10:30 AM - 12:30 PM Central Time

ORF1p Expression Correlates with STING Activation and IFN Signatures in SLE Nonlesional Skin
Abstract Poster Presenter: Mehrnaz Gharaee-Kermani, DVM, MPH, PhD – University of Michigan
10:30 AM - 12:30 PM Central Time

Patient-Reported Quality of Life in SLE: Association with Biomarker-Derived Disease Activity Index (L-DAI) and hSLEDAI in a Prospective Cohort
Abstract Poster Presenter: Bernie Rubin – Progentec Diagnostics
10:30 AM - 12:30 PM Central Time

Physical Activity Patterns and Health-Related Quality of Life in Middle-Aged and Older Adults with Systemic Lupus Erythematosus
Abstract Poster Presenter: Sarah Lieber, MD, MS – Hospital for Special Surgery
10:30 AM - 12:30 PM Central Time

Predicting Type 1 and Type 2 SLE Activity Using the LupusPRO
Abstract Poster Presenter: Amanda Eudy, PhD – Duke University
10:30 AM - 12:30 PM Central Time

Preload deficiency as a treatable cause of fatigue and exercise intolerance in SLE
Abstract Poster Presenter: Yoo Jin Kim, MD, MS – Duke University
10:30 AM - 12:30 PM Central Time

Prevalence and Predictors of Types and Subtypes of Pulmonary Diseases in Systemic Lupus Erythematosus: A Population-Based Cross-Sectional Study Using High-Resolution Computed Tomography Scan and Pulmonary Function Testing
Abstract Poster Presenter: Henrik Zachar Langkilde, MD (he/him/his) – Department of Rheumatology, Odense University Hospital
10:30 AM - 12:30 PM Central Time

Renal Tubular Complement C9 Deposition is Linked to Tubulointerstitial Fibrosis and Progression to Chronic Kidney Disease in Lupus Nephritis
Abstract Poster Presenter: Angela Lu, BS – Albert Einstein College of Medicine
10:30 AM - 12:30 PM Central Time

SLE Genetic Risk Loci in the Context of Environmental Exposure: A Gene-Based Classification and Clinical Insight
Abstract Poster Presenter: Dag Leonard, MD, PhD – Uppsala University
10:30 AM - 12:30 PM Central Time

Specificity of Cell-bound T Cell Biomarkers (TC4d, TIgG, TIgM) in Differentiating SLE from ANA-Associated Rheumatic Diseases
Abstract Poster Presenter: Vasileios Kyttaris, MD, PhD – BIDMC
10:30 AM - 12:30 PM Central Time

Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease Among Patients with Systemic Lupus Erythematosus
Abstract Poster Presenter: Aakash Patel, MD – Massachusetts General Hospital
10:30 AM - 12:30 PM Central Time

The 2019 EULAR/ACR and 2012 SLICC Classification Criteria for SLE Should Be Applied with Caution as Diagnostic Criteria
Abstract Poster Presenter: Luca Mazzoleni, -None- – University of Brescia
10:30 AM - 12:30 PM Central Time

The Age-Adjusted Charlson Comorbidity Index (CCI) Predicts All-Cause Mortality in Systemic Lupus Erythematosus (SLE) Patients: Data from the Almenara Lupus Cohort
Abstract Poster Presenter: Benny Rashuamán-Conche, MD (he/him/his) – Hospital Guillermo Almenara Irigoyen.
10:30 AM - 12:30 PM Central Time

The Clinical Utility of a Multianalyte Lupus Risk Score Incorporating Cell-bound Complement Activation Products: A Systematic Evaluation
Abstract Poster Presenter: Vasileios Kyttaris, MD, PhD – BIDMC
10:30 AM - 12:30 PM Central Time

The Presence of Avascular Necrosis in Patients with Systemic Lupus Erythematosus Undergoing Total Knee Arthroplasty is Not Associated with Worse Outcomes
Abstract Poster Presenter: Billy Kim, MD – Hospital for Special Surgery
10:30 AM - 12:30 PM Central Time

Whole Blood Immune Phenotyping Reveals Cytometric Differences in B Cell Clusters Between Lupus Nephritis and Non-Lupus Nephritis SLE Patients with Minimal Proteinuria
Abstract Poster Presenter: Nicholas Bauer, BS – Oklahoma Medical Research Foundation